Spr Vet Med Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 0.92%
(FY 2022)
- Profit 72.83%
(FY 2022)
- Ebitda 171.65%
(FY 2022)
- Net Worth 127.80%
(FY 2022)
- Total Assets -45.50%
(FY 2022)
About Spr Vet Med Pharma
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyanka Aggarwal and Harish Kumar serve as directors at the Company.
- CIN/LLPIN
U51909DL2017PTC317475
- Company No.
317475
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Spr Vet Med Pharma Private Limited offer?
Spr Vet Med Pharma Private Limited offers a wide range of products and services, including Animal Feed Supplement, Poultry Feed Supplements.
Who are the key members and board of directors at Spr Vet Med Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Aggarwal  | Director | 30-Dec-2019 | Current |
| Harish Kumar | Additional Director | 15-Dec-2022 | Current |
Financial Performance of Spr Vet Med Pharma.
Spr Vet Med Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.92% increase. The company also saw a substantial improvement in profitability, with a 72.83% increase in profit. The company's net worth Soared by an impressive increase of 127.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spr Vet Med Pharma?
Unlock access to Spr Vet Med Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Spr Vet Med Pharma?
Spr Vet Med Pharma has a workforce of 7 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spr Vet Med Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spr Vet Med Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
